The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.
Hao
Ming-xiu
MX
Department of Geriatrics, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Jiang
Li-sheng
LS
Fang
Ning-yuan
NY
Pu
Jun
J
Hu
Liu-hua
LH
Shen
Ling-Hong
LH
Song
Wei
W
He
Ben
B
D000818:Animals; D048588:Benzoxazines / Q000494:pharmacology*; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism; D002186:Cannabinoids / Q000494:pharmacology*; D002460:Cell Line; D006801:Humans; D007249:Inflammation / Q000139:chemically induced* / Q000378:metabolism / Q000517:prevention & control*; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D009025:Morpholines / Q000494:pharmacology*; D009281:Naphthalenes / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D048588:Benzoxazines; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D008077:Lipoproteins, LDL; D009025:Morpholines; D009281:Naphthalenes; D017382:Reactive Oxygen Species; D014409:Tumor Necrosis Factor-alpha; C099252:oxidized low density lipoprotein; C070417:(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone